Q3 2018 EPS Estimates for Morgan Stanley (MS) Boosted by Oppenheimer

Morgan Stanley (NYSE:MS) – Stock analysts at Oppenheimer raised their Q3 2018 EPS estimates for shares of Morgan Stanley in a report released on Wednesday, April 18th. Oppenheimer analyst C. Kotowski now anticipates that the financial services provider will earn $1.08 per share for the quarter, up from their prior forecast of $1.06. Oppenheimer also issued estimates for Morgan Stanley’s Q4 2018 earnings at $0.96 EPS, FY2018 earnings at $4.61 EPS and FY2019 earnings at $5.00 EPS.

How to Become a New Pot Stock Millionaire

MS has been the subject of a number of other research reports. Sanford C. Bernstein started coverage on shares of Morgan Stanley in a research report on Monday, April 9th. They set an “underperform” rating and a $51.00 target price for the company. Societe Generale cut shares of Morgan Stanley from a “buy” rating to a “hold” rating in a research report on Tuesday, January 9th. Vining Sparks restated a “buy” rating and set a $60.00 target price on shares of Morgan Stanley in a research report on Monday, January 8th. Royal Bank of Canada restated a “buy” rating and set a $60.00 target price on shares of Morgan Stanley in a research report on Friday, January 19th. Finally, Keefe, Bruyette & Woods restated a “buy” rating and set a $62.00 target price on shares of Morgan Stanley in a research report on Thursday, April 5th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. Morgan Stanley presently has a consensus rating of “Buy” and an average target price of $55.31.

Shares of NYSE MS opened at $53.64 on Monday. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 2.75. Morgan Stanley has a 52 week low of $40.43 and a 52 week high of $59.38. The stock has a market capitalization of $97,583.94, a P/E ratio of 14.90, a P/E/G ratio of 0.91 and a beta of 1.54.

Morgan Stanley (NYSE:MS) last announced its quarterly earnings data on Wednesday, April 18th. The financial services provider reported $1.45 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.28 by $0.17. Morgan Stanley had a net margin of 15.09% and a return on equity of 11.10%. The firm had revenue of $11.08 billion during the quarter, compared to analysts’ expectations of $10.37 billion. During the same quarter last year, the business earned $1.00 earnings per share. The business’s revenue for the quarter was up 13.7% compared to the same quarter last year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, May 15th. Stockholders of record on Monday, April 30th will be issued a dividend of $0.25 per share. The ex-dividend date of this dividend is Friday, April 27th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.86%. Morgan Stanley’s dividend payout ratio (DPR) is presently 27.78%.

In related news, insider Daniel A. Simkowitz sold 87,050 shares of the business’s stock in a transaction that occurred on Wednesday, February 14th. The shares were sold at an average price of $53.55, for a total value of $4,661,527.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Chairman James P. Gorman sold 100,000 shares of the business’s stock in a transaction that occurred on Thursday, February 15th. The shares were sold at an average price of $55.34, for a total transaction of $5,534,000.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 239,254 shares of company stock valued at $13,085,019. Insiders own 0.19% of the company’s stock.

Institutional investors have recently added to or reduced their stakes in the stock. Exane Derivatives grew its holdings in Morgan Stanley by 303.9% in the fourth quarter. Exane Derivatives now owns 1,979 shares of the financial services provider’s stock valued at $104,000 after purchasing an additional 1,489 shares during the period. First Dallas Securities Inc. acquired a new position in Morgan Stanley during the fourth quarter valued at approximately $121,000. Guidant Wealth Advisors acquired a new position in Morgan Stanley during the fourth quarter valued at approximately $132,000. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA lifted its position in Morgan Stanley by 119.4% during the fourth quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 2,800 shares of the financial services provider’s stock valued at $147,000 after buying an additional 1,524 shares in the last quarter. Finally, Risk Paradigm Group LLC lifted its position in Morgan Stanley by 624.8% during the fourth quarter. Risk Paradigm Group LLC now owns 2,899 shares of the financial services provider’s stock valued at $152,000 after buying an additional 2,499 shares in the last quarter. Hedge funds and other institutional investors own 86.05% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Q3 2018 EPS Estimates for Morgan Stanley (MS) Boosted by Oppenheimer” was reported by Week Herald and is the property of of Week Herald. If you are accessing this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright legislation. The legal version of this piece of content can be read at https://weekherald.com/2018/04/24/q3-2018-eps-estimates-for-morgan-stanley-ms-boosted-by-oppenheimer.html.

About Morgan Stanley

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. The company operates through three segments: Institutional Securities, Wealth Management, and Investment Management.

Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply